Adam Cuker, MD, MS
He/Him
Hematology
Accepting new patients
Sees patients age 18 and up
Penn Blood Disorders Center
Make an appointmentCall 215-615-6555
Headshot of Adam Cuker, MD, MS
Penn Medicine Provider

About me

  • Section Chief, Hematology
  • Clinical Director, Penn Blood Disorders Center
  • Director, Penn Comprehensive and Hemophilia Thrombosis Program
  • Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania
  • Professor of Medicine in Pathology and Laboratory Medicine

Education and training

  • Medical School: Yale University School of Medicine
  • Residency: Mass General Brigham Healthcare Center - Chestnut Hill
  • Fellowship: University of Pennsylvania Health System

What my patients think about me

Average Rating

341 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

January 2026
just comfortable with my doctor
January 2026
Dr. Cuker answered all of my questions and is a very caring physician!
January 2026
dr is a good communicator
December 2025
great doctor who takes his time and explains everything very well! great communication and he is always pleasant, thoughtful, and engaging!

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Cuker is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Cuker A, Rux AH, Hinds JL, Dela Cruz M, Yarovoi SV, Brown IAM, Yang W, Konkle BA, Arepally GM, Watson SP, Cines DB, Sachais BS Novel diagnostic assays for heparin-induced thrombocytopenia , Blood, 121(18): 2013,3727-3732

Cuker A, Cines DB Protamine-induced thrombocytopenia? , Blood, 121: 2013 ,2818-2819

Siegal D, Cuker A Reversal of novel oral anticoagulants in patients with major bleeding , J Thromb Thrombolysis, 35(3): 2013 ,391-398

Sood S, Cuker A, Wang C, Metjian A, Chiang E, Soucie J, Konkle B Similarity in Joint Function Limitation in Type 3 Von Willebrand Disease and Moderate Haemophilia A , Haemophilia, 19(4): 2013 ,595-601

Tanhehco YC, Cuker A, Rudnick M, Sachais BS Investigation of a potential protective mechanism against heparin-induced thrombocytopenia in patients on chronic intermittent hemodialysis , Thromb Res, 131(3): 2013 ,244-248

Cuker A, Gimotty PA, Crowther MA, Warkentin TE Predictive value of the 4Ts scoring system for heparin-induced thromboctopenia: a systematic review and meta-analysis , Blood, 120(20): 2012 ,4160-4167

Sachais BS, Litvinov RI, Yarovoi SV, Rauova L, Hinds JL, Rux AH, Arepally GM, Poncz M, Cuker A, Weisel JW, Cines DB Dynamic antibody binding properties in the pathogenesis of HIT , Blood, 120(5): 2012,1137-1142

Martinez M, Cuker A, Mills A, Lightfoot R, Fan Y, Tang W, Hazen SL, Ischiropoulos H Nitrated fibrinogen is a biomarker of oxidative stress in venous thromboembolism , Free Radic Biol Med, 53(2): 2012,230-236

Cuker A, Cines DB How I treat heparin-induced thrombocytopenia , Blood, 119(10): 2012 ,2209-2218

Lakshmanan S, Cuker A Comtemporary management of primary immune thrombocytopenia (ITP) in adults , J Thromb Haemost, 10(10): 2012 ,1988-1998